We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Generic Valtrex Approval Triggers Preliminary Injunction Request
One day after the FDA granted first-filer Ranbaxy Pharmaceuticals permission to market valacyclovir hydrochloride tablets, patent holder GlaxoSmithKline quickly moved to stop the generic firm from cutting in on sales of its blockbuster herpes treatment drug, Valtrex.